Drug Development in Psychiatry

Discover the transformative insights in Drug Development in Psychiatry, authored by leading experts and published by Springer International Publishing AG in 2024. This comprehensive volume spans 459 pages and delves into the evolving landscape of psychiatric drug development. The book highlights how novel drugs and innovative disease targets are reshaping clinical trial methodologies, providing essential knowledge for developers and regulatory agencies alike.

Explore the critical role of biomarkers, genetics, and advancements in neuroscience and neuroimaging in influencing drug development strategies. This book is an invaluable resource for professionals seeking to understand how these developments are set to revolutionize psychiatric practice. Enhance your knowledge and stay ahead in the field with this essential read.